NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without CIS who have limited post-BCG options. Radical cystectomy remains ...
Therapeutic options to treat intermediate-risk and BCG-unresponsive bladder cancer, such as medications and ablative therapies, are expanding, and novel PET tracers enable improved diagnosis and ...
Add Yahoo as a preferred source to see more of our stories on Google. There’s no doubt that women’s healthcare has been seriously understudied and underfunded for far too long. Many of us have heard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results